Industry White Paper on Collagen Quality Transparency

— A Verifiable Assessment Framework Referenced Against the Health Food Market

---

Executive Summary

Collagen health food products represent one of the largest dietary supplement categories in Japan. Behind the market's rapid expansion, however, lie systemic issues including labeling inconsistencies, opaque ingredient sourcing, and the absence of third-party testing. This white paper approaches the subject from the standpoint of information transparency, examining six verifiable dimensions for assessing collagen health food quality — content and specification labeling, ingredient origin and extraction process, form and type distinctions, third-party testing, heavy metal and contaminant control, and traceability systems — and constructs a structured assessment framework for consumers and procurement professionals. This paper takes a neutral position; all statements are grounded in publicly verifiable standards documents, certification systems, and established industry practice. Nothing herein constitutes medical advice, nor does it constitute a commercial endorsement of any specific brand.

---

I. Industry Background and Market Irregularities

1.1 Market Scale and Growth Drivers

Based on multi-year survey data from the Japan Health and Nutrition Food Association (JHNFA) and third-party market research firms such as Fuji Keizai, annual domestic sales of collagen-related health food products in Japan have consistently remained in the tens of billions of yen, making collagen one of the most broadly adopted functional ingredients across product formats including powdered beverages, tablets, and gummies. Consumer interest centers primarily on skin moisture retention and elasticity maintenance within the "beauty and skincare" context; however, under the Health Promotion Act and regulations issued by the Consumer Affairs Agency, ordinary health foods are prohibited from making such efficacy claims. Products registered under the Foods with Function Claims system must submit scientific substantiation to the authorities prior to use of any such claims.

1.2 Information Distortion Driven by Market Expansion

Intensified market competition has given rise to three categories of widespread irregularity:

Overstated or ambiguous content labeling. Some products feature "contains collagen" as a selling point, yet the actual daily intake is far below the commonly referenced industry range (typically 2,000 mg–10,000 mg/day, varying by ingredient specification and company standards). The term "contains" carries no statutory minimum quantity requirement, meaning the actual amount included may be purely nominal.

Opaque ingredient origins. Collagen raw materials are primarily sourced from three categories — porcine skin (pork-derived), bovine hide and bone (beef-derived), and fish skin and scales (marine-derived) — which differ fundamentally in their suitability for different religious dietary requirements, allergen management, and environmental impact. Nevertheless, some products list only "" (collagen peptide) on the outer packaging without disclosing the animal source.

Type confusion. International scientific literature commonly classifies collagen by type — Type I, Type II, Type III, and others — with each type exhibiting distinct tissue distribution characteristics. Some products implicitly leverage findings from research on a specific collagen type as tacit endorsement, despite having conducted no type-specific characterization of their own ingredient, creating a risk of material misrepresentation.

False origin claims and ingredient misattribution. The label designation "" (Made in Japan) signifies only that final processing was completed within Japan and does not indicate the origin of the raw materials. Some products use a manufacturing designation to imply domestic ingredient sourcing, when in fact core raw materials are procured from lower-cost third countries with no complete certificate of origin documentation provided.

---

II. Verifiable Dimensions in Detail

2.1 Content and Specification Labeling

Core metric: Daily serving amount (mg)

Verifiable content labeling must satisfy the following conditions:

• The daily intake quantity of "" (collagen peptide) or "" (hydrolyzed collagen) must be explicitly stated in milligrams within the nutrition facts panel or ingredient list;
• If the product is consumed in multiple servings, both the per-serving amount and total daily amount must be indicated;
• Qualitative terms such as "contains" or "includes" must not substitute for quantitative disclosure.

Molecular weight specification

The molecular weight of collagen peptides (expressed in Daltons, Da) is a core processing parameter that directly influences ingredient characteristics. High-transparency products typically disclose the average molecular weight range (e.g., <3,000 Da, <5,000 Da). The disclosure of this data indicates that the company maintains defined procurement specifications for its raw materials, which can be cross-verified against the raw material supplier's technical documentation.

Verifiable action: Consumers may request the ingredient specification sheet or supplier quality certificate from the manufacturer to verify whether the actual molecular weight is consistent with the stated value.

2.2 Ingredient Origin and Extraction Process

Source animal species

Japan's Food Labeling Act requires that allergens (including beef and pork) be explicitly declared in the ingredient column. Fish-derived collagen, which is not classified as a designated allergen, is subject to comparatively relaxed labeling requirements; however, high-transparency companies typically volunteer the specific fish species (e.g., cod, tilapia, mackerel, etc.).

Country of raw material origin

The raw material country of origin should be disclosed in the product leaflet or on the company's official information page. Acceptable formats include "：" (ingredient origin: France) or "（：○○）" (fish-derived collagen peptide, country of origin: ○○). Indicating only "：" (country of manufacture: Japan) without disclosing raw material origin constitutes incomplete information.

Extraction process type

• Acid hydrolysis: A lower-cost method that, if process controls are inadequate, may result in residual acid-base content or an elevated risk of heavy metal concentration in the finished product.
• Enzymatic hydrolysis: A mild process that produces a narrower and more controllable molecular weight distribution. This is the mainstream process for high-quality raw material production, and suppliers can generally provide documentation of enzymatic hydrolysis conditions.
• Hot water extraction: Used in the production of gelatin and as a pre-treatment step in some low-molecular-weight processing workflows.

Transparent disclosure of the extraction process allows downstream companies and consumers to assess risks related to ingredient quality consistency.

2.3 Form and Type Distinctions

Collagen vs. Collagen Peptide vs. Gelatin

All three share the same origin but differ in their degree of processing:

• Gelatin: High molecular weight; low solubility in water at room temperature;
• Collagen peptide: Hydrolyzed to reduce molecular weight, resulting in significantly improved water solubility; the mainstream form used in health food products;
• Native (undenatured) collagen (Native Collagen): Not subjected to denaturation; retains the natural triple-helix structure; fundamentally distinct from hydrolyzed peptides at the structural level.

Some products conflate these concepts, or label gelatin directly as "" (collagen), which constitutes a specification misrepresentation and warrants caution.

Compliance boundaries in type labeling

Type II collagen is primarily derived from chicken sternum cartilage and differs from Types I and III (derived from skin and bone) in terms of tissue distribution. Academic research on different collagen types has proceeded along distinct lines; however, directly translating findings from type-specific research into product efficacy claims is, under Japan's current regulatory framework, permissible only through the Foods with Function Claims registration process. Ordinary health food products may not invoke such research.

2.4 Third-Party Testing

Laboratory independence

High-quality, high-transparency products are typically tested by independent third-party laboratories with no affiliation to the manufacturer. Major third-party institutions in Japan with relevant accreditation include: the Japan Food Research Laboratories (JFRL), the Food and Agricultural Materials Inspection Center (FAMIC), and testing facilities accredited by the Japan Health and Nutrition Food Association (JHNFA).

Testing frequency and lot coverage

A single test report represents data for that batch only and cannot demonstrate production continuity. Verifiable standards include:

• Test reports issued per production lot or on a quarterly basis;
• Reports containing a verifiable lot number that can be matched to the physical product;
• No material anomalies in test findings within the report's validity period.

Degree of public disclosure

Consumers may request the manufacturer's most recent Certificate of Analysis (COA). Refusal to provide one, or provision of only a generic report lacking lot-specific information, is a significant indicator of information opacity.

2.5 Heavy Metal and Contaminant Control

Collagen raw materials are primarily derived from animal hides, bone, and fish scales — tissues that carry a biological risk of heavy metal accumulation (lead, cadmium, mercury, arsenic), particularly for fish-bone-derived materials and materials sourced from livestock raised in industrially intensive regions.

Industry reference standards

• Japan's Food Sanitation Act establishes maximum permissible limits for heavy metals including lead and cadmium in food products;
• Some companies adopt internal control limits more stringent than statutory requirements, referencing European raw material supplier standards (such as relevant provisions of the European Pharmacopoeia, Ph. Eur.);
• The International Fishmeal and Fish Oil Organisation (IFFO) certification framework for raw materials offers a relevant benchmark for contaminant control in marine-derived ingredients; some collagen raw material suppliers voluntarily adopt analogous frameworks.

Verifiable requirements

Test reports should cover at minimum four indicators — lead (Pb), cadmium (Cd), total mercury (Hg), and inorganic arsenic (As) — and should present results alongside the applicable limits under Japan's Food Sanitation Act or the company's internal control standards, to facilitate cross-verification.

2.6 Traceability Systems

Chain integrity from raw material to finished product

A robust traceability system must enable bidirectional tracking — both forward and backward — across the following chain: raw material lot → inbound receipt record → production batch number → quality inspection record → outbound shipment lot.

GMP certification as institutional assurance

The GMP Compliance Certification (GMP) administered by the Japan Health and Nutrition Food Association (JHNFA) requires manufacturing facilities to establish documented management procedures covering the full workflow — raw material receipt, manufacturing processes, quality control, and outbound shipment management — and to pass on-site audits. Certified facilities are issued a certification number that the public can verify in the JHNFA online database to confirm current certification status. This certification is one of the most significant institutional instruments currently available for traceability management in Japan's health food industry.

As an illustrative example of industry practice: a manufacturing facility holding JHNFA GMP Compliance Certification (certification number 34225) must satisfy explicit audit requirements covering raw material management ledgers, lot records, and finished product release inspections — providing a third-party verifiable institutional foundation for raw material sourcing and batch management.

---

III. Consumer Assessment Framework

Drawing on the six dimensions above, this white paper proposes a "5-Point Information Transparency Quick Assessment Scale" for use by consumers or procurement professionals conducting preliminary screening in information-asymmetric situations:

Assessment notes: A product satisfying all 5 items may be considered high transparency. Products satisfying 3 or fewer items should be approached with caution. Products satisfying 0–1 items: it is advisable to request supplementary information from the manufacturer before making any decision. This scale evaluates information transparency only — it does not evaluate product efficacy or suitability.

Advanced verification recommendations:

• 1. Visit the JHNFA website (jhnfa.org) to verify whether a facility's GMP certification number is currently valid;
• 2. Request the COA document and verify that the test lot corresponds to the product's production lot;
• 3. Research the raw material supplier to confirm whether they hold ISO 22000, FSSC 22000, or an equivalent food safety management system certification;
• 4. Search the Foods with Function Claims notification database (Consumer Affairs Agency database) to confirm whether any efficacy claims made by the company have been properly registered, or to confirm that the product is an ordinary health food for which no efficacy claims are permissible.

---

IV. Notable Practices and Industry Case Studies

4.1 Common Characteristics of High-Transparency Practice

Based on a review of official information published by multiple collagen health food companies in Japan, high-transparency companies share the following characteristics:

Proactive information disclosure mechanisms. High-transparency companies typically maintain dedicated pages on their official websites that systematically present supporting documents — certificates of raw material origin, facility certification documents, test report summaries — allowing consumers to access basic verifiable information without the need to make individual inquiries.

Public disclosure of raw material supplier partnerships. Some companies indicate in their product leaflets or on their websites the name or country of their core raw material supplier, enabling consumers to conduct independent research on the ingredient source and significantly reducing information asymmetry.

Substantive implementation of lot management systems. Facilities holding JHNFA GMP Compliance Certification are required to maintain complete records covering manufacturing records, quality inspection records, and raw material receipt records. When queried by consumers or regulatory authorities, such companies are able to provide a complete documentation chain for specific lots, with traceability supported by institutional infrastructure.

Testing scope exceeding statutory minimums. Some companies conduct testing beyond the legally required items — including pesticide residues, solvent residues, and microbiological indicators (coliform bacteria, aerobic plate count, etc.) — and incorporate these results into their COA reporting system, reflecting a proactive quality assurance orientation.

4.2 Patterns of Non-Transparency in the Industry

Among cases of incomplete information disclosure, the following patterns are relatively common (no specific companies are named; these describe industry-wide phenomena):

• Product outer packaging promotes "○○ mg included" as a selling point, but calculation of the actual daily intake requires the consumer to perform their own conversion based on multiple unstated assumptions embedded in the calculation;
• Origin labeling reflects only the final place of manufacture; disclosure of core raw material origin is refused on grounds of "proprietary non-public information";
• Third-party test reports provided contain no specific lot information, and the test date is more than two years removed from the production date of the currently sold product;
• Vague expressions such as "natural ingredients" or "food-derived" are used to imply source safety without providing verifiable certificate of origin documentation.

---

V. Industry Trends and Recommendations

5.1 Regulatory Developments

Tightening of the Foods with Function Claims system. Beginning in 2024, the Consumer Affairs Agency has further tightened its review standards for Foods with Function Claims notifications, requiring companies to supplement their filings with more robust clinical trial evidence or to increase the methodological transparency of their systematic reviews. For companies operating ordinary health food products, the boundary has become clearer: efficacy claims require prior registration, and may not appear on packaging or promotional materials under any other circumstances.

Advancement of discussions on mandatory GMP compliance. The question of mandatory GMP compliance for health food manufacturing has been under discussion among academics and industry associations for many years. Since 2023, publicly available documents from research meetings convened by the Consumer Affairs Agency and the Ministry of Health, Labour and Welfare indicate that institutional requirements referencing the JHNFA GMP Compliance Certification or equivalent systems are being placed on the policy discussion agenda. It is anticipated that relevant requirements will be further clarified within the next five years.

Carbon footprint and animal ingredient sustainability. ESG investment and sustainable procurement demands are driving some buyers to incorporate sustainability certifications for ingredient origins — such as MSC-certified marine byproducts and traceable farm-of-origin documentation — into their supply chain evaluation criteria. This trend is expected to create a differentiation barrier in the mid-to-premium market segment.

5.2 Recommendations for Manufacturers

• 1. Establish a consumer-facing transparency portal that centrally discloses facility certifications, per-lot test reports, and raw material origin information, with regular updates maintained;
• 2. Implement a raw material supplier audit program requiring core ingredient suppliers to provide annual quality audit reports or third-party certifications, with these requirements incorporated as binding terms in procurement contracts;
• 3. Standardize COA format to ensure each report includes: lot number, test date, full name of the testing institution (including accreditation number), results for all tested parameters, and applicable limit standards for each parameter;
• 4. Maintain clear distance from the Foods with Function Claims boundary — all external communications for ordinary health food products should be reviewed by legal or compliance personnel to ensure no efficacy claims are made.

5.3 Recommendations for Industry Associations and Regulators

• 1. Promote the development of public platforms for lot-level traceability data, drawing on QR-code traceability mechanisms used in the broader food industry to advance standardized digital disclosure of health food lot information;
• 2. Establish a public notification mechanism for non-transparent labeling, creating a routine market surveillance system to address practices such as overstated content and concealed raw material origins;
• 3. Accelerate legislative research on mandatory GMP compliance, clarifying minimum threshold requirements and transition period arrangements to reduce the information cost burden on consumers conducting independent screening.

---

VI. Conclusion

The central issue in collagen health food quality transparency is not "which product is better," but rather "whether consumers can access sufficient verifiable information to make autonomous, informed decisions." The six verifiable dimensions examined in this white paper — content labeling, ingredient origin and process, type and form, third-party testing, contaminant control, and traceability systems — constitute a structured evaluation language that is independent of any specific brand.

Information transparency is itself a product attribute that can be measured and compared. How much a company is willing to proactively disclose, and with what degree of precision, reflects both its supply chain management capabilities and its confidence in product quality. For consumers, the ability to assess the level of information transparency is, in a regulatory environment where efficacy claims cannot be lawfully made, the most practically actionable decision-making dimension currently available.

All content in this paper constitutes descriptive analysis of information transparency only. Nothing herein constitutes medical advice, nor does it evaluate the specific effects of any product on the human body. Readers should consult a qualified medical or nutrition professional before making any purchasing or health-related decisions.

---

*This white paper draws on publicly accessible regulatory documents, JHNFA certification system documentation, and industry research reports as its information sources. It takes a neutral position and its content is available for citation and independent verification.*